These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 29510390)

  • 21. The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.
    Fatseas M; Debrabant R; Auriacombe M
    Curr Opin Psychiatry; 2012 May; 25(3):219-25. PubMed ID: 22449768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA;
    Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use disorders in association with attention-deficit/hyperactivity disorder, co-morbid mental disorders, and medication in a nationwide sample.
    Steinhausen HC; Bisgaard C
    Eur Neuropsychopharmacol; 2014 Feb; 24(2):232-41. PubMed ID: 24314850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention deficit hyperactivity disorder and substance use disorders.
    Szobot CM; Bukstein O
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk behaviours among substance use disorder treatment seekers with and without adult ADHD symptoms.
    Kaye S; Gilsenan J; Young JT; Carruthers S; Allsop S; Degenhardt L; van de Glind G; van den Brink W
    Drug Alcohol Depend; 2014 Nov; 144():70-7. PubMed ID: 25193717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention-deficit/hyperactivity disorder and early-onset substance use disorders.
    Wilson JJ; Levin FR
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):751-63. PubMed ID: 16262592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.
    Zulauf CA; Sprich SE; Safren SA; Wilens TE
    Curr Psychiatry Rep; 2014 Mar; 16(3):436. PubMed ID: 24526271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comorbidity of substance use disorders and attention-deficit hyperactivity disorders: pathogenesis and therapy].
    Fallgatter AJ; Jacob CP
    Nervenarzt; 2009 Sep; 80(9):1015-21. PubMed ID: 19672572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Substance use disorders and ADHD: an overview of recent Dutch research].
    van Emmerik-van Oortmerssen K; Crunelle CL; Carpentier PJ
    Tijdschr Psychiatr; 2013; 55(11):861-6. PubMed ID: 24242145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use.
    Cunill R; Castells X; González-Pinto A; Arrojo M; Bernardo M; Sáiz PA; Flórez G; Torrens M; Tirado-Muñoz J; Fonseca F; Arranz B; Garriga M; Goikolea JM; Zorrilla I; Becoña E; López A; San L
    Adicciones; 2022 Apr; 34(2):168-178. PubMed ID: 34171106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention Deficit Hyperactivity Disorder in Prisoners: Increased Substance Use Disorder Severity and Psychiatric Comorbidity.
    Vélez-Pastrana MC; González RA; Ramos-Fernández A; Ramírez Padilla RR; Levin FR; Albizu García C
    Eur Addict Res; 2020; 26(4-5):179-190. PubMed ID: 32615575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of substance use disorder on ADHD and its treatment.
    Wilens TE; Upadhyaya HP
    J Clin Psychiatry; 2007 Aug; 68(8):e20. PubMed ID: 17876905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.
    Castells X; Ramos-Quiroga JA; Rigau D; Bosch R; Nogueira M; Vidal X; Casas M
    CNS Drugs; 2011 Feb; 25(2):157-69. PubMed ID: 21254791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adult attention deficit hyperactivity disorder (ADHD) with comorbid addictive disorder. Therapeutic challenges using the example of a survey of clinical practice].
    Adorjan K; Karch S; Martin G; Plörer D; Winter C; Hantschk I; Koller G; Erbas B; Pogarell O
    MMW Fortschr Med; 2019 Jul; 161(Suppl 5):7-12. PubMed ID: 31313269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
    van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
    Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attention Deficit Hyperactivity Disorder Increases Nicotine Addiction Severity in Adults Seeking Treatment for Substance Use Disorders: The Role of Personality Disorders.
    Sánchez-García NC; González RA; Ramos-Quiroga JA; van den Brink W; Luderer M; Blankers M; Grau-Lopez L; Levin FR; Kaye S; Demetrovics Z; van de Glind G; Schellekens A; Vélez-Pastrana MC;
    Eur Addict Res; 2020; 26(4-5):191-200. PubMed ID: 32564016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of comorbid substance use disorder during long-term central stimulant treatment in adult ADHD.
    Torgersen T; Gjervan B; Rasmussen K; Vaaler A; Nordahl HM
    Atten Defic Hyperact Disord; 2013 Mar; 5(1):59-67. PubMed ID: 23104523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Diagnosis in Patients with Substance Use Disorder and/or Attention-Deficit/Hyperactivity Disorder Using Continuous Performance Test.
    Slobodin O; Blankers M; Kapitány-Fövény M; Kaye S; Berger I; Johnson B; Demetrovics Z; van den Brink W; van de Glind G
    Eur Addict Res; 2020; 26(3):151-162. PubMed ID: 32074617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility.
    Adler LA; Guida F; Irons S; Rotrosen J; O'Donnell K
    Postgrad Med; 2009 Sep; 121(5):7-10. PubMed ID: 19820269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.